Identification of Biomarkers of Venous Thromboembolism by Bioinformatics Analyses

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2018 Apr 6

PMID 29620629

Citations 5

Authors

Guiming Wang

Wenbo Zhao

Yudong Yang

Gaochao Yang

Zhigang Wei

Jiansheng Guo

Affiliations

Soon will be listed here.

Abstract

Venous thromboembolism (VTE) is a common vascular disease and a major cause of mortality. This study intended to explore the biomarkers associated with VTE by bioinformatics analyses.Based on Gene Expression Omnibus (GEO) database, the GSE19151 expression profile data were downloaded. The differentially expressed genes (DEGs) between single VTE (sVTE)/recurrent VTE (rVTE) and control were identified. Then, pathway enrichment analysis of DEGs were performed, followed by protein-protein interaction (PPI) network construction.Total 433 upregulated and 222 downregulated DEGs were obtained between sVTE and control samples. For rVTE versus control, 625 upregulated and 302 downregulated DEGs were identified. The overlap DEGs were mainly enriched in the pathways related to ribosome, cancer, and immune disease. The DEGs specific to rVTE were enriched in several pathways, such as nod-like receptor signaling pathway. In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (RPL9), RPL5, RPS20, RPL23, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE.

Citing Articles

Exploration of the causal relationship and mechanisms between serum albumin and venous thrombosis: a bidirectional mendelian randomization analysis and bioinformatics study.

Xia X, Tie X, Hong M, Yin W Thromb J. 2025; 23(1):17.

PMID: 40033322 PMC: 11874119. DOI: 10.1186/s12959-025-00700-4.

Bioinformatics-based discovery of biomarkers and immunoinflammatory infiltrates in hip fractures complicating deep vein thrombosis: A STROBE.

Fu Z, Song C, Mei Y, Zhou D, Zhou Y, Chen J Medicine (Baltimore). 2025; 103(52):e40809.

PMID: 39969342 PMC: 11688061. DOI: 10.1097/MD.0000000000040809.

CREB1 Silencing Protects Against Inflammatory Response in Rats with Deep Vein Thrombosis Through Reducing RPL9 Expression and Blocking NF-κB Signaling.

Jian X, Yang D, Wang L, Wang H J Cardiovasc Transl Res. 2023; 17(3):570-584.

PMID: 37891366 DOI: 10.1007/s12265-023-10450-1.

Deep sequencing of circulating miRNAs and target mRNAs level in deep venous thrombosis patients.

Wang Q, Chang Y, Yang X, Han Z IET Syst Biol. 2023; 17(4):212-227.

PMID: 37466160 PMC: 10439493. DOI: 10.1049/syb2.12071.

Identification of four hub genes in venous thromboembolism via weighted gene coexpression network analysis.

Fan G, Jin Z, Wang K, Yang H, Wang J, Li Y BMC Cardiovasc Disord. 2021; 21(1):577.

PMID: 34861826 PMC: 8642897. DOI: 10.1186/s12872-021-02409-4.

References

Kwon A, Jo S, Jo Y, Park J, Kim M, Kang H . Genetic polymorphisms and plasma levels of tissue factor and tissue factor pathway inhibitor in venous thromboembolism. Blood Coagul Fibrinolysis. 2014; 25(5):416-21. DOI: 10.1097/MBC.0000000000000063. View

Prandoni P, Falanga A, Piccioli A . Cancer and venous thromboembolism. Lancet Oncol. 2005; 6(6):401-10. DOI: 10.1016/S1470-2045(05)70207-2. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P . The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2010; 39(Database issue):D561-8. PMC: 3013807. DOI: 10.1093/nar/gkq973. View

Fritz J, Ferrero R, Philpott D, Girardin S . Nod-like proteins in immunity, inflammation and disease. Nat Immunol. 2006; 7(12):1250-7. DOI: 10.1038/ni1412. View

Heit J, Mohr D, Silverstein M, Petterson T, OFallon W, Melton 3rd L . Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000; 160(6):761-8. DOI: 10.1001/archinte.160.6.761. View

Lewis D, Stashenko G, Akay O, Price L, Owzar K, Ginsburg G . Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism. Thromb Res. 2011; 128(6):536-40. PMC: 3726737. DOI: 10.1016/j.thromres.2011.06.003. View

Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A . ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009; 25(8):1091-3. PMC: 2666812. DOI: 10.1093/bioinformatics/btp101. View

Zimmerman G, Weyrich A . Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol. 2008; 28(3):s17-24. PMC: 2594008. DOI: 10.1161/ATVBAHA.107.160218. View

10.

Germain M, Saut N, Greliche N, Dina C, Lambert J, Perret C . Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One. 2011; 6(9):e25581. PMC: 3181335. DOI: 10.1371/journal.pone.0025581. View

11.

Kringen P, Wang Y, Dumeaux V, Nesland J, Kristensen G, Borresen-Dale A . TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival. BMC Cancer. 2005; 5:134. PMC: 1276789. DOI: 10.1186/1471-2407-5-134. View

12.

de Visser M, Van Minkelen R, van Marion V, den Heijer M, Eikenboom J, Vos H . Genome-wide linkage scan in affected sibling pairs identifies novel susceptibility region for venous thromboembolism: Genetics In Familial Thrombosis study. J Thromb Haemost. 2013; 11(8):1474-84. DOI: 10.1111/jth.12313. View

13.

Weyrich A, Lindemann S, Tolley N, Kraiss L, Dixon D, Mahoney T . Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost. 2004; 30(4):491-8. DOI: 10.1055/s-2004-833484. View

14.

Rosendaal F . Venous thrombosis: a multicausal disease. Lancet. 1999; 353(9159):1167-73. DOI: 10.1016/s0140-6736(98)10266-0. View

15.

Livingstone L, White A, Sprouse J, Livanos E, Jacks T, Tlsty T . Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 1992; 70(6):923-35. DOI: 10.1016/0092-8674(92)90243-6. View

16.

Irizarry R, Bolstad B, Collin F, Cope L, Hobbs B, Speed T . Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003; 31(4):e15. PMC: 150247. DOI: 10.1093/nar/gng015. View

17.

Larsen T, Sorensen H, Skytthe A, Johnsen S, Vaupel J, Christensen K . Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology. 2003; 14(3):328-32. View

18.

Chen G, Shaw M, Kim Y, Nunez G . NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol. 2008; 4:365-98. DOI: 10.1146/annurev.pathol.4.110807.092239. View

19.

Fox E, Kahn S . The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 2005; 94(2):362-5. DOI: 10.1160/TH05-04-0266. View

20.

Spencer F, Emery C, Lessard D, Anderson F, Emani S, Aragam J . The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006; 21(7):722-7. PMC: 1924694. DOI: 10.1111/j.1525-1497.2006.00458.x. View